Jpmorgan Chase & Co »

Corcept Therapeutics Incorporated shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $12M 253k 46.28
2024-06-30 $5.7M 177k 32.49
2024-03-31 $4.9M 194k 25.19
2023-12-31 $6.5M 200k 32.48
2023-09-30 $5.2M 193k 27.25
2023-06-30 $5.0M 223k 22.25
2023-03-31 $6.3M 291k 21.66
2022-12-31 $4.9M 242k 20.31
2022-06-30 $9.5M 229k 41.67
2022-03-31 $4.9M 216k 22.52
2021-12-31 $0 211k 0.00
2021-03-31 $4.5M 190k 23.80
2020-12-31 $5.2M 199k 26.16
2020-09-30 $1.9M 106k 17.99
2020-06-30 $1.1M 63k 17.13
2020-03-31 $483k 41k 11.91
2019-12-31 $491k 41k 12.06
2019-09-30 $524k 37k 14.15
2019-06-30 $376k 34k 11.17
2019-03-31 $1.8M 156k 11.69
2018-12-31 $508k 30k 17.24
2018-09-30 $1.5M 111k 13.29
2018-06-30 $1.1M 67k 15.73
2018-03-31 $3.7M 228k 16.46
2017-12-31 $3.2M 176k 18.05
2017-06-30 $26k 2.2k 11.88
2017-03-31 $131k 12k 10.97
2016-12-31 $507k 70k 7.26
2013-09-30 $46k 29k 1.60
2013-06-30 $52k 29k 1.77